Verona Pharma Plc News - VRP

Verona Pharma plc Verona Pharma Plc Operational Update And Financial Results For The First Quarter Ended March 31, 2018

Announced positive top-line data from two Phase 2 clinical trials ahead of schedule Met primary and key secondary endpoints in 403 patient Phase...

Verona Pharma plc Verona Pharma To Present At Bioeurquity Europe 2018

LONDON, May 04, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma"), a clinical-stage...

Verona Pharma plc Verona Pharma Plc : Result Of Agm

LONDON, May 03, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA), a clinical-stage biopharmaceutical company focused on...

Verona Pharma plc Verona Pharma To Announce Operational Update And Financial Results For First Quarter Ended March 31, 2018

LONDON, May 02, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma"), a clinical-stage...

Verona Pharma Chief Medical Officer Kenneth Newman To Resign

News) - Verona Pharma PLC said Wednesday that Kenneth Newman has decided to resign as chief medical officer and the co ...

Verona Pharma plc Verona Pharma Announces Departure Of Chief Medical Officer

LONDON, April 11, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma" or "the Company"), a...

Verona Pharma Shares Rise As It Gets Good Results From RPL554 Trials

News) - Verona Pharma PLC said Monday it has received positive top-line data from its phase 2b study for its proposed ...

Verona Pharma plc Verona Pharma Reports Positive Top-Line Data From Phase 2b Clinical Trial Of Rpl554 For Maintenance Treatme...

Primary endpoint met; RPL554 produced clinically and statistically significant improvements in lung function at all dose levels Clinically...

Verona Pharma plc Verona Pharma To Present At Upcoming Healthcare Investor Conferences

LONDON, March 15, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma"), a clinical-stage...

Verona Pharma plc Verona Pharma Plc: 2017 Annual Report And Accounts And Notice Of Agm

March 9, 2018, LONDON - Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused...

Verona Pharma plc Verona Pharma Plc : Grant Of Options And Rsus And Pdmr Dealings

March 9, 2018, LONDON - Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma"), a clinical-stage biopharmaceutical company focused...

DIRECTOR DEALINGS: Verona Pharma CEO Karlsson Buys 3,250 Shares

News) - Verona Pharma PLC, a clinical-stage biopharmaceutical company, said Thursday that Chief Executive Officer Jan- ...

Verona Pharma plc Verona Pharma Plc : 1st Quarter Results

LONDON, March 08, 2018 (GLOBE NEWSWIRE) -- Verona Pharma plc (AIM:VRP) (Nasdaq:VRNA) ("Verona Pharma"), a clinical-stage...

Verona Pharma PLC Second Price Monitoring Extn

Verona Pharma PLC 02 March 2018 Second Price Monitoring Extension A second and final Price Monitoring Extension has been activated in this...

Verona Pharma PLC Price Monitoring Extension

Verona Pharma PLC 02 March 2018 Price Monitoring Extension The auction call period has been extended in this security by 5 minutes. Auction call...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Verona Pharma Plc (VRP)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

VRP News

Verona Pharma plc Verona Pharma Plc Operational Update And Financial Results For The First Quarter Ended March 31, 2018

Verona Pharma plc Verona Pharma To Present At Bioeurquity Europe 2018

Verona Pharma plc Verona Pharma Plc : Result Of Agm

Verona Pharma plc Verona Pharma To Announce Operational Update And Financial Results For First Quarter Ended March 31, 2018

Verona Pharma Chief Medical Officer Kenneth Newman To Resign

Verona Pharma plc Verona Pharma Announces Departure Of Chief Medical Officer

Verona Pharma Shares Rise As It Gets Good Results From RPL554 Trials

Verona Pharma plc Verona Pharma Reports Positive Top-Line Data From Phase 2b Clinical Trial Of Rpl554 For Maintenance Treatme...

Verona Pharma plc Verona Pharma To Present At Upcoming Healthcare Investor Conferences

Verona Pharma plc Verona Pharma Plc: 2017 Annual Report And Accounts And Notice Of Agm

Verona Pharma plc Verona Pharma Plc : Grant Of Options And Rsus And Pdmr Dealings

DIRECTOR DEALINGS: Verona Pharma CEO Karlsson Buys 3,250 Shares

Verona Pharma plc Verona Pharma Plc : 1st Quarter Results

Verona Pharma PLC Second Price Monitoring Extn

Verona Pharma PLC Price Monitoring Extension

VRP Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Verona Pharma Plc (VRP) News

Verona Pharma Plc (VRP)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

VRP News

Verona Pharma plc Verona Pharma Plc Operational Update And Financial Results For The First Quarter Ended March 31, 2018

Verona Pharma plc Verona Pharma To Present At Bioeurquity Europe 2018

Verona Pharma plc Verona Pharma Plc : Result Of Agm

Verona Pharma plc Verona Pharma To Announce Operational Update And Financial Results For First Quarter Ended March 31, 2018

Verona Pharma Chief Medical Officer Kenneth Newman To Resign

Verona Pharma plc Verona Pharma Announces Departure Of Chief Medical Officer

Verona Pharma Shares Rise As It Gets Good Results From RPL554 Trials

Verona Pharma plc Verona Pharma Reports Positive Top-Line Data From Phase 2b Clinical Trial Of Rpl554 For Maintenance Treatme...

Verona Pharma plc Verona Pharma To Present At Upcoming Healthcare Investor Conferences

Verona Pharma plc Verona Pharma Plc: 2017 Annual Report And Accounts And Notice Of Agm

Verona Pharma plc Verona Pharma Plc : Grant Of Options And Rsus And Pdmr Dealings

DIRECTOR DEALINGS: Verona Pharma CEO Karlsson Buys 3,250 Shares

Verona Pharma plc Verona Pharma Plc : 1st Quarter Results

Verona Pharma PLC Second Price Monitoring Extn

Verona Pharma PLC Price Monitoring Extension

VRP Discussion

Your Recent History